跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
洪 小雅
助理教授
醫學生物技術暨檢驗學系
電話
02-28267167
電子郵件
shaline
nycu.edu
tw
h-index
h10-index
h5-index
235
引文
10
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
138
引文
8
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
72
引文
5
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2008
2024
每年研究成果
概覽
指紋
網路
研究成果
(21)
類似的個人檔案
(6)
指紋
查看啟用 Shiao-Ya Hong 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Lung Adenocarcinoma
100%
Tensin
76%
Non-small Cell Lung Cancer (NSCLC)
70%
Phosphorylation
69%
E3 Ubiquitin Ligase
69%
RNA Replication
66%
Hepatitis delta Antigen
66%
Boron Neutron Capture Therapy
66%
Biological Efficacy
66%
Vaccination
66%
Aurora Kinase A (AURKA)
48%
Hepatitis delta Virus
45%
IgG Levels
44%
Seroconversion Rate
41%
Inflammation
40%
Pancreatic Tumor
40%
Tumorigenicity
39%
Reactogenicity
38%
Cell Proliferation
36%
Expression Pattern
36%
Processive
33%
Uterine Smooth muscle Tumor of Uncertain Malignant Potential
33%
ChAdOx1 nCov-19 Vaccination
33%
Anti-RBD IgG
33%
Anti-spike IgG
33%
Humoral Immunogenicity
33%
SHP-1
33%
Humoral Antibody Response
33%
Lung Squamous Cell Carcinoma
33%
Lipopolysaccharide-induced Inflammation
33%
EGF Receptor
33%
Induced Degradation
33%
Polymerase II
33%
RNA-dependent RNA Polymerase (RdRP)
33%
Tumor Spheroids
33%
Acute Lung Injury
33%
Microfluidic-based
33%
Epithelial Growth Factor Receptor Tyrosine Kinase Inhibitor
33%
Alisertib
33%
Viral
33%
Pulmonary Fibrosis
33%
Macrophages
33%
Allogeneic
33%
Survival Analysis
33%
Assembly Cell
33%
Three-dimensional Self-assembly
33%
Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs)
33%
Dysregulation
33%
Inhibitor Resistant
33%
Epithelial-mesenchymal Transition
33%
Biochemistry, Genetics and Molecular Biology
Tensin
88%
Epidermal Growth Factor Receptor
79%
C-Terminus
75%
Ubiquitin-Conjugating Enzyme
69%
RNA Replication
66%
Hepatitis D
66%
Tumor Spheroid
66%
Serine
66%
Aurora A Kinase
50%
Messenger RNA
47%
Hepatitis Delta Virus
45%
Immunogenicity
44%
Cell Proliferation
41%
Isoform
41%
Seroconversion
41%
Cancer Cell
37%
Fibroblast
36%
Downregulation
33%
RNA Polymerase
33%
Mesenchymal-Epithelial Transition
33%
Antibody Response
33%
Phylogeny
33%
Receptor Tyrosine Kinase Inhibitors
33%
Spike
33%
Growth Factor Receptor
33%
Expression Analysis
33%
Hemodialysis
33%
Upregulation
33%
Promoter Region
33%
Cladistics
33%
SARS Coronavirus
27%
Focal Adhesion
25%
RNA
25%
RNA Polymerase II
22%
Survival Rate
19%
Binding Domain
16%
Receptor Binding
16%
Programmed Cell Death
14%
Ubiquitination
13%
Cell Migration
12%
Genomics
12%
Colon
11%
Cre Recombinase
11%
Mouse Model
11%
Neutron Radiation
11%
Cadherin
11%
Rigidity
11%
Cancer Mortality
11%
Biological Activity
11%
Galactosidase
11%
